Search results for "Hepatitis A"

showing 10 items of 60 documents

Exposure to HAV infection in patients with chronic liver disease in Italy, a multicentre study*.

2005

Summary.  We carried out a multicentre study on 2830 patients with chronic liver disease from 79 liver units (25 in northern, 24 in central and 30 in southern Italy) to evaluate naturally acquired immunity against hepatitis A virus (HAV) in relation to age, sex, geographical area of origin and entity of liver disease, and to define the strategy for specific vaccination. Antibody to HAV (anti-HAV) was detected in 1514 (53.5%) of the 2830 patients tested; the prevalence was 50.4% in males and 59.1% in females. Both in central and southern Italy the prevalence of anti-HAV positive subjects increased with increasing age from 43.3 and 44.7%, respectively, in the 0–30-year-old subjects to 80.1 an…

AdultMalemedicine.medical_specialtyCirrhosisAdolescentHepatitis A AntibodiesChronic liver diseaseLiver diseaseSeroepidemiologic StudiesVirologyInternal medicinePrevalencemedicineHumansIn patientChildChronic liver disease HAV infection HAV vaccination HBV chronic infection HCV chronic infection Total anti-HAVAgedAged 80 and overHigh prevalenceHepatologybiologybusiness.industryLiver DiseasesInfantHepatitis AHepatitis AMiddle Agedmedicine.diseaseVaccinationCross-Sectional StudiesInfectious DiseasesItalyChild PreschoolImmunoglobulin GChronic DiseaseImmunologybiology.proteinFemaleAntibodybusinessHepatitis A Virus Human
researchProduct

Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.

2007

Hepatitis A virus (HAV) or hepatitis B virus (HBV) superinfection is associated with an increased mortality in patients with chronic liver diseases (CLD). Despite official recommendations, it was reported that the vaccination rate against HAV is low in patients with chronic hepatitis C infection. To evaluate the situation in patients with autoimmune liver diseases, we conducted a retrospective cohort study.Susceptibility to HAV and HBV infections, course of HAV and HBV infections, vaccination rates against HAV and HBV, and efficacy of hepatitis A/B vaccines were evaluated by antibody testing in 225 patients with autoimmune liver diseases during 1,677 person-years.Susceptibility to HAV/HBV i…

AdultMalemedicine.medical_specialtyHepatitis B virusvirusesHepatitis A AntibodiesImmunopathologyGermanyEpidemiologymedicineHumansHepatitis B VaccinesHepatitis B AntibodiesRetrospective StudiesAutoimmune diseaseHepatitisHepatitis A VaccinesHepatitis B Surface AntigensHepatologybiologybusiness.industryIncidence (epidemiology)IncidencefungiVaccinationGastroenterologyvirus diseasesbiochemical phenomena metabolism and nutritionHepatitis AMiddle Agedmedicine.diseaseHepatitis BPrognosisdigestive system diseasesVaccinationHepatitis AutoimmuneAntibodies AntinuclearImmunologyDNA Viralbiology.proteinFemaleViral diseaseDisease SusceptibilityHepatitis A virusAntibodybusinessFollow-Up StudiesThe American journal of gastroenterology
researchProduct

Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy

2011

Abstract Background Hepatitis E virus (HEV) is a major cause of acute hepatitis in developing countries, whereas it is not considered a major health problem in Western World. Aims To investigate the spread of HEV and its possible role in causing acute hepatitis in Southern Italy. Methods Four hundred and thirty patients observed from April to December 2009 were studied and grouped as follows: 55 individuals with acute hepatitis (AH), 33 of whom cryptogenic; 321 individuals with chronic liver diseases (CLD), (278 Italians and 43 immigrants); 54 individuals without liver disease (control-group). Serum samples from all cases were tested for IgG anti-HEV antibodies and those positive to this te…

AdultMalemedicine.medical_specialtyvirusesmedicine.disease_causeZOONOSISHepatitisLiver diseaseCHRONIC LIVER-DISEASEYoung AdultHepatitis E virusEpidemiologymedicineHepatitis E virusHumansAcute hepatitisHepatitis AntibodiesHepatologybiologybusiness.industryLiver DiseasesGastroenterologyvirus diseasesMiddle AgedHepatitis Emedicine.diseaseSerum samplesVirologydigestive system diseasesHepatitis EImmunoglobulin MItalyImmunoglobulin GChronic Diseasebiology.proteinRNA ViralFemaleAntibodycryptogenic Acute HepatitisbusinessHepatitis E virus infectionAcute hepatitisSerological diagnosis Hepatitis E Virus Acute hepatitis ZOONOSIS CHRONIC LIVER-DISEASE cryptogenic Acute HepatitisSerological diagnosis
researchProduct

Antiviral activity of alginate-oleic acid based coatings incorporating green tea extract on strawberries and raspberries

2018

Foodborne illnesses caused by the consumption of berries contaminated with human enteric viruses, namely human noroviruses (NoVs) and the hepatitis A virus (HAV), remain a significant food safety concern. The objective of this research was to investigate a food-grade edible coating composed of alginate/oleic and containing green tea extract (GTE) as an antiviral agent for the preservation of fresh strawberries and raspberries. Berries were stored at ambient (25 °C) temperature and refrigerated (10 °C) conditions. Initially, the effect of the pH of the film-forming dispersions (FFD) on their antioxidant and antiviral activity was analysed. Then, the physicochemical properties of edible algin…

AntioxidantGeneral Chemical Engineeringmedicine.medical_treatmentved/biology.organism_classification_rank.speciesGreen tea extractFoodborne virusesmedicine.disease_causeEdible coatings01 natural scienceschemistry.chemical_compound0404 agricultural biotechnology0103 physical sciencesmedicineFood scienceInfectivity010304 chemical physicsbusiness.industryved/biologyAlginate04 agricultural and veterinary sciencesGeneral ChemistryFood safety040401 food scienceHepatitis a virusOleic acidchemistryNorovirusbusinessFood ScienceMurine norovirusGreen tea extract
researchProduct

Application of viability PCR to discriminate the infectivity of hepatitis A virus in food samples.

2015

Abstract Transmitted through the fecal–oral route, the hepatitis A virus (HAV) is acquired primarily through close personal contact and foodborne transmission. HAV detection in food is mainly carried out by quantitative RT-PCR (RT-qPCR). The discrimination of infectious and inactivated viruses remains a key obstacle when using RT-qPCR to quantify enteric viruses in food samples. Initially, viability dyes, propidium monoazide (PMA) and ethidium monoazide (EMA), were evaluated for the detection and quantification of infectious HAV in lettuce wash water. Results showed that PMA combined with 0.5% Triton X-100 (Triton) was the best pretreatment to assess HAV infectivity and completely eliminate…

AzidesHot TemperatureOctoxynolvirusesReal-Time Polymerase Chain ReactionMicrobiologyVirusMicrobiologyCell LinePropidium monoazideVegetablesAnimalsShellfishInfectivityMicrobial ViabilitybiologyInoculationvirus diseasesGeneral MedicineHepatitis Abiology.organism_classificationHepatitis a virusBivalviaReal-time polymerase chain reactionFood MicrobiologySpinachRNA ViralVirus InactivationIndicators and ReagentsHepatitis A virusFood SciencePropidiumInternational journal of food microbiology
researchProduct

Virus entéricos humanos en alimentos: detección y métodos de inactivación

2020

[ES] Los principales patógenos víricos que podemos adquirir ingiriendo alimentos contaminados son los norovirus, el virus de la hepatitis A y el virus de la hepatitis E que se propagan principalmente a través de la vía fecal oral. En los últimos años, la incidencia de brotes de transmisión alimentaria causados por estos patógenos ha experimentado un aumento considerable, en parte debido al comercio globalizado y a los cambios en los hábitos de consumo. Las matrices alimentarias que mayor riesgo representan para el consumidor son los moluscos bivalvos, vegetales de IV gama, frutas tipo baya y platos listos para comer. Actualmente las técnicas moleculares son las más habituales para la detecc…

Cultural StudiesSociology and Political ScienceFood industryViral inactivationmolecular methodsFoodborne virusesBiologymedicine.disease_causeGeneral WorksFood safety03 medical and health sciencesseguridad alimentariaAmedicineenvases virucidas030304 developmental biologyinactivación víricaInfectivityviral inactivationmetagenomicscompuestos virucidas0303 health sciencesantiviral packaging030306 microbiologybusiness.industryvirus entéricosGeneral Arts and Humanitiesdigestive oral and skin physiologyfoodborne virusesFoodborne outbreakHepatitis AFood safetymedicine.diseaseVirologyantiviral compoundsVirusMolecular methodsfood safetymétodos molecularesAliments ContaminacióViral genomesAntiviral packagingmetagenómicaNorovirusAntiviral compoundsMetagenomicsbusinessContaminated foodArbor
researchProduct

Antiviral activity of aged green tea extract in model food systems and under gastric conditions.

2018

Aged-green tea extract (GTE) is known to reduce the infectivity of hepatitis A virus (HAV) and murine norovirus (MNV), a human norovirus surrogate, in vitro and in washing solutions. Initially, the effect of aged-GTE was evaluated on virus like particles (VLPs) of human norovirus (HuNoV) genogroup I (GI) by a porcine gastric mucine (PGM)-enzyme-linked immunosorbent assay (ELISA) and transmission electron microscopy (TEM), and on HuNoV GI suspensions by an in situ capture-RT-qPCR method, suggesting that HuNoVs are very sensitive to aged-GTE treatment at 37 °C. Moreover, the potential application of aged-GTE was evaluated using model foods and simulated gastric conditions. Then, aged-GTE samp…

Food Handlingvirusesved/biology.organism_classification_rank.speciesGreen tea extractmedicine.disease_causeMicrobiologyAntiviral AgentsVirusCell LineFoodborne Diseases03 medical and health sciencesMicemedicineAnimalsFood scienceFood model systems030304 developmental biologyInfectivityOrange juice0303 health sciencesTea030306 microbiologyved/biologyChemistryPlant ExtractsNorovirusSimulated gastric fluidGeneral MedicineMacaca mulattaIn vitroFruit and Vegetable JuicesTiterMilkRAW 264.7 CellsNorovirusHuman norovirusHepatitis A virusGreen tea extractFood ScienceMurine norovirusInternational journal of food microbiology
researchProduct

Processing Strategies to Inactivate Hepatitis A Virus in Food Products: A Critical Review

2015

Hepatitis A infection, caused by hepatitis A virus (HAV), is the leading cause of human viral hepatitis throughout the world and is mainly propagated via the fecal–oral route. Transnational outbreaks of food-borne infections are reported with increasing frequency as a consequence of international food trade. Food-borne outbreaks caused by HAV are mainly associated with bivalve molluscs, produce (soft fruits and leafy greens), and ready-to-eat meals. The purpose of this paper was to conduct a structured and systematic review of the published literature on the current state of knowledge regarding the stability of HAV in foods as well as the efficacy of food processing strategies and to identi…

Food tradebusiness.industryvirusesdigestive oral and skin physiologyHepatitis A InfectionOutbreakBiologyFood safetymedicine.diseaseHepatitis a virusBiotechnologyFood productsFood processingmedicinebusinessViral hepatitisFood ScienceComprehensive Reviews in Food Science and Food Safety
researchProduct

Organ-specificity and diagnostic value of cell-mediated immunity against a liver-specific membrane protein: Studies in hepatic and non-hepatic diseas…

1975

In chronic active hepatitis (CAH, n=58) 70% of the HBsAg negative and 48% of the HBsAg positive cases showed a CMI against human liver specific proteins (HLPI). Using HBsAg as antigen only 12% of the HBsAg negative and 24% of the HBsAg positive cases gave a CMI response. On the basis of HBsAg and autoantibodies in the serum CAH patients could be divided into 4 subgroups. A close correlation between CMI against HLPI, sex, ANA and HL-A-8 could be detected. In a follow-up study of patients with acute virus B hepatitis (n=62) CMI against HBsAg was detected in 60% of the cases in the acute phase of the disease but in 15% only 3-6 months after the onset of the illness (n=40). In patients who deve…

HBsAgTuberculinBiologyAntibodiesVirusHepatitisAntigen-Antibody ReactionsHepatitis B AntigensSex FactorsAntigenAntibody SpecificityImmunityNeoplasmsDrug DiscoveryDiabetes MellitusLeukocytesmedicineHumansTuberculosisGenetics (clinical)AutoantibodiesHepatitisImmunity CellularLiver DiseasesAutoantibodyMuscle SmoothGeneral MedicineHepatitis Amedicine.diseaseVirus DiseasesAntibodies AntinuclearCell Migration InhibitionChronic DiseaseImmunologyMolecular MedicineOrgan SpecificityKlinische Wochenschrift
researchProduct

The diagnostic significance of intrahepatocellular hepatitis-B-surface-antigen (HB s Ag), hepatitis-B-core-antigen (HB c Ag) and IgG for the classifi…

1975

Liver biopsies of patients with inflammatory liver diseases and clinically healthy HBsAg-carriers were examined for presence of intracellular HBsAg, HBcAg and IgG by direct immunofluorescence. The studies revealed the following results: 1. In most cases healthy HBsAg-carriers had HBsAg in the cytoplasm, but they did never show HBcAg in the nuclei of hepatocytes. 2. In the early phase some patients with HBsAg-positive acute hepatitis had HBcAg and/or HBsAg in their hepatocytes. In a normal course with complete recovery the immunoelimination may clear either phenomenon at variable stages of the disease. 3. Cases one year after complete recovery of acute virus B-hepatitis had no HB-components …

HBsAgVirusHepatitis B AntigensAntigenDrug DiscoverymedicineHumansDirect fluorescent antibodyGenetics (clinical)Cell NucleusHepatitismedicine.diagnostic_testbusiness.industryLiver cellvirus diseasesGeneral MedicineHepatitis Amedicine.diseasedigestive system diseasesHBcAgLiverVirus DiseasesImmunoglobulin GLiver biopsyAcute DiseaseCarrier StateChronic DiseaseImmunologyMolecular MedicinebusinessKlinische Wochenschrift
researchProduct